AHR gene expression and the polymorphism rs2066853 are associated with clinicopathological parameters in colorectal carcinoma

Tracie Cheng, Sujani Madhurika Kodagoda Gamage, Dinu Hewage, Cu Tai Lu, Sharmin Aktar, Vinod Gopalan, Alfred King yin Lam*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

The relationship between red and processed meat and its risk toward colorectal carcinoma (CRC) is not fully explored in literature. Polycyclic aromatic hydrocarbons (PAHs) are procarcinogenic molecules that are ingested with meat cooked at high temperatures. The metabolic conversion of PAHs to carcinogenic diol epoxides is in part mediated by the aryl hydrocarbon receptor (AhR)–dependent induction of CYP1A1. This study aims to examine the expression profiles and polymorphisms of the AHR (aryl hydrocarbon receptor) gene which is involved in the metabolic conversion of PAHs in patients with CRC. Genetic analysis was done in matched cancer and non-neoplastic tissues from 79 patients diagnosed with CRCs. Low AHR mRNA expression was associated with mucinous colorectal adenocarcinoma. Exon 10 of AHR showed that 27% of patients had the rs2066853 single-nucleotide polymorphism resulting in an arginine-to-lysine change at codon 554. This variant was significantly associated with a lower likelihood of perineural invasion, presence of synchronous cancer, and multiple colorectal polyps. Furthermore, rs2066853 individuals were significantly more likely to be of more advanced age and have a more favorable tumor grade and pathological stage. These results imply the pathogenic roles of AHR in PAH-associated colorectal carcinogenesis.

Original languageEnglish
Pages (from-to)50-59
Number of pages10
JournalHuman Pathology
Volume122
Early online date9 Feb 2022
DOIs
Publication statusPublished - Apr 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'AHR gene expression and the polymorphism rs2066853 are associated with clinicopathological parameters in colorectal carcinoma'. Together they form a unique fingerprint.

Cite this